NDC Pharmacologic Class N0000182139 Cytochrome P450 2B6 Inhibitors [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0069-8140Xalkori CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-8141Xalkori CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
17772-131Qelbree Viloxazine HydrochlorideCapsule, Extended ReleaseOralSupernus Pharmaceuticals, IncHuman Prescription Drug
17772-132Qelbree Viloxazine HydrochlorideCapsule, Extended ReleaseOralSupernus Pharmaceuticals, IncHuman Prescription Drug
17772-133Qelbree Viloxazine HydrochlorideCapsule, Extended ReleaseOralSupernus Pharmaceuticals, IncHuman Prescription Drug
70127-100Epidiolex CannabidiolSolutionOralGreenwich Biosciences, Inc.Human Prescription Drug

There are 6 NDC products with the pharmacologic class Cytochrome P450 2B6 Inhibitors [MoA].